Financial statements Dexfor

Balance sheet of Dexfor

Company age:
Age:
8 y. 7 m. 7 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of DEXFOR

Year
2018
2019
2021
2022
2023
Total assets 2 235 580,32 3 177 264,38 7 519 148,00 5 154 709,63 5 035 839,81
A. Fixed assets - 0,00 15 000,05 14 722,28 32 472,28
B. Current assets 2 235 580,32 3 177 264,38 7 504 147,95 5 139 987,35 5 003 367,53
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 2 235 580,32 3 177 264,39 7 519 148,00 5 154 709,63 5 034 716,55
A. Equity 924 613,90 874 536,86 773 214,60 760 013,80 740 838,18
B. Liabilities and provisions for liabilities 1 310 966,42 2 302 727,53 6 745 933,40 4 394 695,83 4 293 878,37
I. Long-term liabilities - 43 149,73 0,00 12 563,22 0,00
II. Short-term liabilities 1 310 966,42 2 259 577,80 6 745 933,40 4 382 132,61 4 293 878,37
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.